Organon & Co (NYSE:OGN) — Stock Price
Organon & Co (NYSE:OGN) is currently trading at $13.62 USD, up 0.15% today. Over the past 52 weeks, shares have ranged between $5.70 and $13.62. This page tracks Organon & Co's live share price on the NYSE exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see market value of Organon & Co.
Organon & Co (OGN) Stock Price Chart — Daily History & Trading Volume
The chart below tracks Organon & Co's daily closing share price and trading volume on the NYSE exchange over the past year, giving a clear view of recent price momentum and liquidity.
Organon & Co Income Statement — Revenue, Profit & Earnings by Year
Organon & Co's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Revenue | $6.22 Billion | $6.40 Billion | $6.26 Billion | $6.17 Billion | $6.30 Billion |
| Cost of Revenue | $2.85 Billion | $2.69 Billion | $2.52 Billion | $2.29 Billion | $2.38 Billion |
| Gross Profit | $3.36 Billion | $3.71 Billion | $3.75 Billion | $3.88 Billion | $3.92 Billion |
| Research & Development | $366.00 Million | $469.00 Million | $528.00 Million | $471.00 Million | $443.00 Million |
| SG&A | $1.72 Billion | $1.55 Billion | $1.68 Billion | $1.45 Billion | $1.43 Billion |
| Total Operating Expenses | $2.09 Billion | $2.23 Billion | $2.42 Billion | $2.17 Billion | $2.01 Billion |
| Operating Income | $1.28 Billion | $1.49 Billion | $1.33 Billion | $1.71 Billion | $1.92 Billion |
| EBITDA | $1.28 Billion | $1.60 Billion | $1.44 Billion | $1.76 Billion | $1.98 Billion |
| EBIT | $929.00 Million | $1.33 Billion | $1.20 Billion | $1.54 Billion | $1.79 Billion |
| Interest Expense | $504.00 Million | $520.00 Million | $527.00 Million | $422.00 Million | $258.00 Million |
| Income Before Tax | $425.00 Million | $807.00 Million | $673.00 Million | $1.12 Billion | $1.53 Billion |
| Income Tax Expense | $238.00 Million | $-57.00 Million | $-350.00 Million | $205.00 Million | $178.00 Million |
| Net Income | $187.00 Million | $864.00 Million | $1.02 Billion | $917.00 Million | $1.35 Billion |
Organon & Co Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes Organon & Co's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Assets | $12.87 Billion | $13.10 Billion | $12.06 Billion | $10.96 Billion | $10.68 Billion |
| Total Current Assets | $4.35 Billion | $4.35 Billion | $4.51 Billion | $3.93 Billion | $3.76 Billion |
| Cash & Equivalents | $574.00 Million | $675.00 Million | $693.00 Million | $706.00 Million | $737.00 Million |
| Short-term Investments | — | — | — | — | — |
| Net Receivables | $1.43 Billion | $1.49 Billion | $1.86 Billion | $1.61 Billion | $1.51 Billion |
| Inventory | $1.41 Billion | $1.32 Billion | $1.31 Billion | $1.00 Billion | $915.00 Million |
| Property, Plant & Equipment | $1.46 Billion | $1.32 Billion | $1.36 Billion | $1.23 Billion | $973.00 Million |
| Goodwill | $4.15 Billion | $4.68 Billion | $4.60 Billion | $4.60 Billion | $4.60 Billion |
| Total Liabilities | $12.12 Billion | $12.63 Billion | $12.13 Billion | $11.85 Billion | $12.19 Billion |
| Total Current Liabilities | $2.39 Billion | $2.72 Billion | $2.92 Billion | $2.51 Billion | $2.60 Billion |
| Long-term Debt | $8.63 Billion | $8.86 Billion | $8.75 Billion | $8.90 Billion | $9.12 Billion |
| Net Debt | $8.23 Billion | $8.36 Billion | $8.24 Billion | $8.41 Billion | $8.63 Billion |
| Total Stockholder Equity | $752.00 Million | $472.00 Million | $-70.00 Million | $-892.00 Million | $-1.51 Billion |
| Retained Earnings | $1.11 Billion | $1.01 Billion | $443.00 Million | $-331.00 Million | $-998.00 Million |
Organon & Co Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how Organon & Co generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Cash Flow | $700.00 Million | $939.00 Million | $799.00 Million | $858.00 Million | $2.46 Billion |
| Capital Expenditures | $162.00 Million | $351.00 Million | $261.00 Million | $427.00 Million | $488.00 Million |
| Free Cash Flow | $538.00 Million | $588.00 Million | $538.00 Million | $431.00 Million | $1.97 Billion |
| Investing Cash Flow | $-390.00 Million | $-513.00 Million | $-260.00 Million | $-420.00 Million | $-481.00 Million |
| Financing Cash Flow | $-561.00 Million | $-368.00 Million | $-569.00 Million | $-433.00 Million | $-1.33 Billion |
| Dividends Paid | $88.00 Million | $297.00 Million | $294.00 Million | $290.00 Million | $145.00 Million |
| Stock-Based Compensation | $77.00 Million | $105.00 Million | $101.00 Million | $75.00 Million | $59.00 Million |
| Depreciation | $361.00 Million | $277.00 Million | $236.00 Million | $212.00 Million | $195.00 Million |
| Change in Cash | $-101.00 Million | $-18.00 Million | $-13.00 Million | $-31.00 Million | $667.00 Million |
Organon & Co Earnings History — EPS Actual vs. Analyst Estimates
Track Organon & Co's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| Apr 30, 2026 | 0.71 | 0.85 | -16.23% |
| Feb 12, 2026 | 0.63 | 0.76 | -17.11% |
| Oct 30, 2025 | 1.01 | 0.93 | +8.60% |
| Aug 05, 2025 | 1.00 | 0.94 | +6.38% |
| May 01, 2025 | 1.02 | 0.89 | +14.61% |
| Feb 13, 2025 | 0.90 | 0.87 | +3.45% |
| Oct 31, 2024 | 0.87 | 0.90 | -3.33% |
| Aug 06, 2024 | 1.12 | 1.08 | +3.70% |